NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $96,750 | +39.7% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $69,250 | -23.1% | 25,000 | -50.0% | 0.00% | 0.0% |
| Q4 2022 | $90,000 | -15.1% | 50,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $106,000 | -21.5% | 50,000 | 0.0% | 0.00% | -40.0% |
| Q2 2022 | $135,000 | -37.8% | 50,000 | 0.0% | 0.01% | -37.5% |
| Q1 2022 | $217,000 | -16.2% | 50,000 | 0.0% | 0.01% | -20.0% |
| Q4 2021 | $259,000 | -15.6% | 50,000 | 0.0% | 0.01% | -23.1% |
| Q3 2021 | $307,000 | -39.2% | 50,000 | 0.0% | 0.01% | -35.0% |
| Q2 2021 | $505,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 16,298,006 | $16,298,000 | 8.49% |
| Madrona Venture Group, LLC | 6,020,770 | $31,188,000 | 5.89% |
| ArchPoint Investors | 1,449,551 | $7,509,000 | 2.23% |
| Ally Bridge Group (NY) LLC | 1,225,060 | $6,346,000 | 2.22% |
| Affinity Asset Advisors, LLC | 1,049,721 | $5,438,000 | 1.98% |
| Tikvah Management LLC | 1,231,835 | $6,381,000 | 1.78% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $10,360,000 | 0.82% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $1,356,000 | 0.74% |
| Perceptive Advisors | 18,222,302 | $94,390,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,144,000 | 0.46% |